Core--Swine model

$0P01FY2002HLNIH

University Of Virginia Charlottesville, Charlottesville VA

Investigators

Linked publications & trials

Paper 38747455 Paper 37426658 Paper 35935999 Paper 34320835 Paper 32673538 Paper 32538902 Paper 32531833 Paper 32386455 Paper 32131612 Paper 32054669 Paper 31725756 Paper 31219225 Paper 31047003 Paper 31026415 Paper 30702996 Paper 30702993 Paper 30580568 Paper 30476957 Paper 30293769 Paper 30249512 Paper 29903734 Paper 29875409 Paper 29850765 Paper 29618726 Paper 29545616 Paper 29348025 Paper 29310992 Paper 29147686 Paper 28970806 Paper 28935758 Paper 28605287 Paper 28596372 Paper 28572160 Paper 28473443 Paper 28473441 Paper 28360338 Paper 28360089 Paper 28319871 Paper 28209220 Paper 28107429 Paper 28091533 Paper 28081824 Paper 28062489 Paper 27931771 Paper 27841660 Paper 27831500 Paper 27820700 Paper 27617863 Paper 27496857 Paper 27482882 Paper 27386937 Paper 27346802 Paper 27237700 Paper 27102965 Paper 26964999 Paper 26868208 Paper 26848137 Paper 26828068 Paper 26825471 Paper 26806306 Paper 26780907 Paper 26629403 Paper 26599207 Paper 26363057 Paper 26361154 Paper 26285907 Paper 26232430 Paper 26227873 Paper 26091486 Paper 26082558 Paper 26044956 Paper 25991812 Paper 25990461 Paper 25953646 Paper 25946330 Paper 25943842 Paper 25847970 Paper 25838429 Paper 25835440 Paper 25762306 Paper 25724068 Paper 25683179 Paper 25614280 Paper 25609772 Paper 25524916 Paper 25297940 Paper 25251155 Paper 25169167 Paper 25104056 Paper 24704628 Paper 24687132 Paper 24613321 Paper 24610640 Paper 24603695 Paper 24530664 Paper 24376657 Paper 24308836 Paper 24124113 Paper 24115031 Paper 24095954

Abstract

The Specific Aims of the Core are: 4) To produce, maintain and monitor swine in various combinations of diabetes and lipemia, and provide tissue, serum, plasma and urine samples as well as blood monocytes and arterial smooth muscle and endothelial cells from these animals as dictated by the needs of scientific projects in this PPG; 5) To provide pathological analysis (including quantitative image analysis), on gross, histological and cellular specimens derived from these animals, and carry out or assist in immunohistochemical studies on specimens as required by the scientific projects. 6) To develop modifications of the diabetic swine model for studies applicable to the human disease (ex., impaired glucose tolerance), together with techniques for delivering pharmacological interventions (ex., osmotic mini-pumps, time-release pellets); 7) To develop, in collaborations with investigators at UVA (Sarembock, French, Nadler), a coronary artery stent model in the diabetic swine model.

View original record on NIH RePORTER →